Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis.

Debnath PK, Chattopadhyay J, Mitra A, Adhikari A, Alam MS, Bandopadhyay SK, Hazra J.

J Ayurveda Integr Med. 2012 Jul;3(3):141-9. doi: 10.4103/0975-9476.100180.

2.

Ayurvedic management of pulmonary tuberculosis: A systematic review.

Samal J.

J Intercult Ethnopharmacol. 2015 Nov 13;5(1):86-91. doi: 10.5455/jice.20151107020621. eCollection 2016 Jan-Feb. Review.

3.

Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.

Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M.

Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. Review.

PMID:
20528765
4.
5.
6.

The Ayurvedic Pharmacopoeia of India, development and perspectives.

Joshi VK, Joshi A, Dhiman KS.

J Ethnopharmacol. 2017 Feb 2;197:32-38. doi: 10.1016/j.jep.2016.07.030. Epub 2016 Jul 9.

PMID:
27404231
7.

[Tuberculosis Annual Report 2011--(4) Tuberculosis treatment and treatment outcomes].

[No authors listed]

Kekkaku. 2013 Sep;88(9):677-86. Japanese.

PMID:
24298695
8.

[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].

Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.

Kekkaku. 2003 Nov;78(11):683-9. Review. Japanese.

PMID:
14672045
9.

Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.

Nagaraja C, Shashibhushan BL, Asif M, Manjunath PH, Sagar C.

Indian J Chest Dis Allied Sci. 2012 Jan-Mar;54(1):23-6.

PMID:
22779119
10.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
11.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
12.

Cancer--an ayurvedic perspective.

Balachandran P, Govindarajan R.

Pharmacol Res. 2005 Jan;51(1):19-30. Review.

PMID:
15519531
13.

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.

Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B.

J Antimicrob Chemother. 2003 Dec;52(6):981-6. Epub 2003 Nov 12.

PMID:
14613962
14.

[Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid].

Nagayama N, Shishido Y, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.

Kekkaku. 2004 May;79(5):341-8. Japanese.

PMID:
15211874
15.
16.

Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.

Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, RĂ¼sch-Gerdes S.

East Afr Med J. 1999 Jun;76(6):307-13.

PMID:
10750516
17.

Resistance pattern in drug-resistant pulmonary tuberculosis.

Nagaraja C, Shashibhushan BL, Sagar C, Asif M, Manjunath PH.

J Postgrad Med. 2011 Jul-Sep;57(3):181-3. doi: 10.4103/0022-3859.85197.

18.

Therapeutic potentials of metals in ancient India: A review through Charaka Samhita.

Galib, Barve M, Mashru M, Jagtap C, Patgiri BJ, Prajapati PK.

J Ayurveda Integr Med. 2011 Apr;2(2):55-63. doi: 10.4103/0975-9476.82523.

19.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
20.

[Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].

Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H.

Kekkaku. 1994 Nov;69(11):671-80. Japanese.

PMID:
7837720

Supplemental Content

Support Center